Proteomics

Proteomics is only one strand of life sciences research or a field that is comprehensively tasked with elucidating various biological molecules in terms of their structure and interaction within cells and organisms. The discovery and validation of protein biomarkers and drug targets is integral to the development of many pharmaceuticals and diagnostics. Proteomics research represents a multi-billion market for mass spectrometry, liquid chromatography, electrophoresis, arrays and immunoassays.

loading... Loading...
Published: | Price: {{result.PriceString}}
...

No reports match your search criteria.


RSS Subscription
{{ pageDetailsDisplay }}
Published: May 13, 2015 | Price: $4,200.00
Proteomics research is increasingly involved in the development of modern clinical medicine from the identification of drug targets, the validation of biomarkers, and optimization of resulting drug leads and assays.  Pharmaceutical and diagnostic companies spend tens of billions of dollars on...
Published: Sep 4, 2014 | Price: $4,200.00
Proteomics Markets for Clinical IVD Applications and Research Applications Kalorama Information report Proteomics Markets for Research and IVD Applications contains market estimates, forecasts and competitive analysis of this important area. Proteomics is the science of proteins, including the...
Published: May 1, 2011 | Price: $2,995.00
The future of the pharmaceutical market will be determined by biologics - drugs produced by natural organisms or recombinant techniques consisting of proteins and other products derived from living organisms for the treatment or management of diseases or injuries. What are the products that lead...
Published: May 1, 2009 | Price: $2,995.00
Cell culture is a major foundation of biopharmaceutical development, bioprocessing and manufacturing. As the biopharmaceutical market grows, so should interest in the cell culture products market. Biopharmaceutical products are developed from large, complex protein molecules, which require equally...
Published: Dec 1, 2008 | Price: $995.00
The substances utilized for what is commonly referred to as 'protein therapeutics' have one thing in common they are all composed primarily of á-amino acids; and these á-amino acids are linked together by a distinct chemical bond known as a “peptide” bond. Used in a...
Published: Jan 1, 2008 | Price: $995.00
Parts of the gene expression analysis market continue to develop in a somewhat predictable manner, whereas other segments are becoming increasingly complex and volatile. The main products—microarrays and RT-PCR—continue to gain widespread acceptance and to see revenues grow rapidly. ...
Published: Jan 1, 2007 | Price: $4,300.00
As the biopharmaceutical market grows, so will the cell culture products market. Cell culture is a major foundation of biopharmaceutical development, bioprocessing and manufacturing. Biopharmaceutical products are developed from large, complex protein molecules, which require equally complex...
Published: Nov 1, 2006 | Price: $995.00
Protein biomarkers have become the hot application area for mass spectrometry (MS) and other proteomics-related technologies in the last few years. In the short term, this move towards biomarkers and clinical proteomics research has happened mainly in the drug discovery and development process. ...
Published: Jun 1, 2006 | Price: $995.00
The protein therapeutics sector is a story of triumphant science, representing both life-saving treatments for millions and a multi-billion dollar industry. This report details both the scientific and business aspects of the protein therapeutics marketplace, including market size and growth,...
Published: Jan 1, 2006 | Price: $2,995.00
In the Spring of 2003, Kalorama published its first report on Outsourcing in Drug Discovery. Since then, so much has changed, the use of the term "2nd Edition" hardly seems appropriate. This new study involved completely re-examining the market from the ground up. This new report is designed to...
Published: Jan 1, 2006 | Price: $995.00
With the mapping of the human genome and the concomitant explosion of proteomics, a steady stream of biopharmaceuticals have been launched—recombinant therapeutic proteins, monoclonal antibody-based products used for therapeutic or in vivo diagnostic purposes, and nucleic acid-based products....
Published: Nov 1, 2003 | Price: $1,875.00
The process of creating a new drug is lengthy and complex. From discovery to development to market, there are numerous pitfalls. In this report, Kalorama focuses on one of the trickiest yet also most promising areas: the interface between discovery and development known as lead optimization. The...
Published: Sep 1, 2002 | Price: $2,999.00
Kalorama's Proteomics 50: Competing Technologies & Alliances in an Emerging Industry November 2001 Abstract: With the Human Genome Project in its culminating phase, scientists are turning to the task of converting the soon to be completed DNA sequence into information that will improve human...
Published: Nov 1, 2001 | Price: $1,497.00
With the Human Genome Project in its culminating phase, scientists are turning to the task of converting the soon to be completed DNA sequence into information that will improve human medicine and health care. One of the key challenges ahead is understanding how proteins direct biological...
Published: | Price: {{result.PriceString}}
...
{{ pageDetailsDisplay }}

No reports match your search criteria.